Steiner H, Berger AP, Godoy-Tundidor S et al: An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6. Eur J Cancer 40: 1066-1072, 2004.
Shepherd FA, Giaccone G, Seymour L et al: Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Marimastat After Respons to First-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer 10.1200/JC0.2002.02.108. J Clin Oncol 20: 4434-4439, 2002.
Bramhall SR, Schulz J, Nemunaitis J et al: A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer. Br J Cancer 87: 161-167, 2002.
Fukuoka M, Yano S, Giaccone G et al: Multiinstitutional randomized phase H trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial)[corrected]. J Clin Oncol 21: 2237-2246, 2003.